Core Viewpoint - The article discusses the controversy surrounding "Antarctic krill oil" products linked to Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., which has led to regulatory investigations and significant brand management actions by the company [1][5][9]. Group 1: Regulatory Actions - The Chengdu New District Market Supervision Administration has established a joint investigation team to look into the "Antarctic krill oil" incident, with the case currently under investigation [1]. - The company has been ordered to stop the sale of the implicated products and is required to compensate consumers as per regulatory guidelines [5]. Group 2: Company Response - Beijing Tongrentang Group issued an apology for the damage caused to consumers and initiated a zero-tolerance brand management action, including a comprehensive investigation of the involved products [5]. - The company is pursuing legal action against the involved parties for trademark infringement and misleading consumers regarding the use of the "Beijing Tongrentang" name [9]. Group 3: Product Quality Concerns - A product marketed as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to have a phospholipid content of 0, raising concerns about product authenticity [7]. - The product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, which has been criticized for its brand management and quality control practices [9]. Group 4: Brand Reputation - Beijing Tongrentang, a historic brand established in 1669, has faced multiple trust crises due to issues related to brand licensing and quality control of its subsidiary products [9].

Group 1 - ByteDance is reported to potentially achieve a net profit of approximately $50 billion for the year, following a claim of around $40 billion in net profit for the first three quarters of 2025, but insiders have stated that these figures are inaccurate and significantly deviated from reality [1][7] - The world's first commercial supercritical carbon dioxide power generation unit, named "Super Carbon No. 1," has successfully commenced operations in Guizhou, China, with a capacity of 15 megawatts, achieving over 85% efficiency improvement and over 50% increase in net power generation compared to traditional steam generation methods [2][7] Group 2 - The U.S. military is reportedly conducting strong retaliatory actions against ISIS in Syria, following the killing of American personnel, with full support from the Syrian transitional government [4][9] - The National Development and Reform Commission, the State Administration for Market Regulation, and the National Internet Information Office have issued rules prohibiting platform operators from colluding to manipulate market prices using platform rules, data, and algorithms [5][9] Group 3 - Beijing Tongrentang has issued an apology regarding the controversy surrounding its Antarctic krill oil products, announcing a comprehensive brand rectification initiative, including a thorough investigation and immediate product recall [3][10] - The Shanghai Consumer Protection Committee has expressed support for Tongrentang's acknowledgment of the issue and its proposed corrective measures, emphasizing the importance of consumer feedback in assessing the effectiveness of these actions [5][11] Group 4 - Moore Threads has launched a new GPU architecture named "Huagang," which boasts a 50% increase in computing density and a tenfold improvement in energy efficiency, capable of supporting clusters of over 100,000 cards [6][12] - U.S. stock markets saw gains, with the Dow Jones up 0.38%, the Nasdaq up 1.31%, and the S&P 500 up 0.89%, driven by strong performances from major tech stocks [6][13]

中新网上海12月20日电 (记者 陈静)北京同仁堂集团20日就"南极磷虾油"相关问题发表声明，上海市消 保委对此表示高度关注。 上海市消保委方面表示，该委欢迎北京同仁堂集团正视问题的态度。北京同仁堂集团在声明中致歉广大 消费者和社会各界，并表示要依法依规对消费者进行赔偿，要开展"零容忍"品牌严管专项行动等等，体 现了对消费者权益的重视和整改的决心，值得肯定。 最后，上海市消保委依法对南极磷虾油产品问题开展社会监督和消费提醒，既是履行保护消费者合法权 益的本职，也是旨在净化健康功能性食品市场和维护中华老字号信誉。北京同仁堂品牌已有356年历 史，其在广大消费者心目中的地位是由历代经营者和无数工匠的心血累积起来的，需要格外珍惜。所 以，上海市消保委方面期望北京同仁堂集团能以此次事件为契机，推进实施品牌长效维护和增信机制， 共同维护健康有序的消费环境，让"北京同仁堂"这块金字招牌越来越亮。(完) 其次，北京同仁堂集团推出的整改措施，实际上也回应了上海市消保委在约谈相关经营者过程中，代表 广大消费者提出的诉求。上海市消保委方面表示，不过，最终整改结果如何，还是要由事实说了算，特 别是要由广大消费者的切实感受说了算。所 ...

Core Viewpoint - Tongrentang has initiated a special task force to investigate the products involved in a recent controversy regarding "99% high-purity Antarctic krill oil," which allegedly contains false ingredient labeling. The company is taking legal action against the responsible parties to protect consumer rights and brand integrity [5][6]. Group 1 - Tongrentang has ordered the involved distributor, Sichuan Health Pharmaceutical Co., to cease sales of the disputed product and has initiated a full process review and traceability of the product [5][6]. - The company has stated that the product in question was unauthorizedly labeled with "Beijing Tongrentang," which is considered illegal, prompting the company to pursue legal action against the involved enterprises [5][6]. - Tongrentang clarified that it does not hold any equity or investment rights in Sichuan Health Pharmaceutical, which is not a subsidiary of the company, although it is a subsidiary of Tongrentang Group [5][6]. Group 2 - The announcement emphasized that the trademarks "Tongrentang" and "Beijing Tongrentang" are owned by Tongrentang Group, and the company and some subsidiaries are licensed to use these trademarks on their products [6]. - As part of its efforts to protect consumer rights, Tongrentang will conduct a comprehensive investigation into brand usage and clean up any improper trademark usage, while also standardizing the identification of authorized stores on e-commerce platforms [5][6].

Core Viewpoint - Beijing Tongrentang Group expresses deep concern and regret over recent public attention regarding "Antarctic Krill Oil," and has initiated a zero-tolerance brand management action to address consumer rights violations [2]. Group 1: Immediate Actions Taken - A special task force has been dispatched to Sichuan to conduct a thorough investigation of the involved products [2]. - The company has ordered and is supervising the immediate removal of the implicated products from the market, ensuring compliance with regulatory requirements for consumer compensation [2]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [2]. Group 2: Brand Protection Measures - A comprehensive investigation into illegal and irregular brand usage across all levels of the group is being conducted [4]. - A brand cleanup initiative is underway to eliminate improper use of the "Tongrentang" name and ensure strict brand management [4]. - The company is standardizing the branding of authorized e-commerce stores to ensure the correct use of the "Tongrentang" double-dragon logo, guiding consumers to identify legitimate purchasing channels [4].

人民财讯12月20日电，上海市消保委发布关于北京同仁堂（600085）集团声明的表态，北京同仁堂集团 于12月20日就"南极磷虾油"相关问题发布声明，上海市消保委对此表示高度关注。上海市消保委欢迎北 京同仁堂集团正视问题的态度。北京同仁堂集团在声明中致歉广大消费者和社会各界，并表示要依法依 规对消费者进行赔偿，要开展"零容忍"品牌严管专项行动等，体现了对消费者权益的重视和整改的决 心，值得肯定。北京同仁堂集团推出的整改措施，实际上也回应了上海市消保委在约谈相关经营者过程 中，代表广大消费者提出的诉求。不过，最终整改结果如何，还是要由事实说了算，特别是要由广大消 费者的切实感受说了算。所以，希望北京同仁堂集团能将各项整改举措落实到位。 ...

Group 1 - Beijing Tongrentang Group issued a statement on December 20 regarding issues related to "Antarctic krill oil," which has drawn significant attention from the Shanghai Consumer Protection Committee [1] - The company acknowledged the problem and expressed regret to consumers and society, committing to legal compensation for consumers and launching a "zero tolerance" brand management initiative, reflecting its commitment to consumer rights and rectification [1] - The corrective measures introduced by Beijing Tongrentang respond to the demands raised by the Shanghai Consumer Protection Committee during discussions with relevant operators, although the effectiveness of these measures will ultimately be judged by consumer experiences [1] Group 2 - The Shanghai Consumer Protection Committee is conducting social supervision and consumer reminders regarding the Antarctic krill oil product issues, fulfilling its role in protecting consumer rights and aiming to purify the health functional food market while maintaining the reputation of time-honored brands [1] - Beijing Tongrentang, with a history of 356 years, holds a significant position in the minds of consumers, which necessitates careful preservation [1] - The company is expected to use this incident as an opportunity to implement long-term brand maintenance and trust-building mechanisms, contributing to a healthy and orderly consumption environment [1]

Core Viewpoint - Beijing Tongrentang Group has acknowledged issues related to "Antarctic Krill Oil" and is taking corrective measures in response to consumer concerns raised by the Shanghai Consumer Protection Committee [1] Group 1: Company Response - The company has shown a proactive attitude in addressing the problems identified with its Antarctic Krill Oil products [1] - Corrective measures introduced by the company are a direct response to the demands of consumers represented by the Shanghai Consumer Protection Committee during discussions with relevant operators [1] - The effectiveness of these corrective actions will ultimately be judged by the actual experiences of consumers [1] Group 2: Regulatory Oversight - The Shanghai Consumer Protection Committee is conducting social supervision and consumer reminders regarding the Antarctic Krill Oil product issues [1] - This oversight is part of the committee's responsibility to protect consumer rights and aims to purify the market for health functional foods [1] - The initiative also seeks to maintain the reputation of time-honored Chinese brands [1]

Core Viewpoint - Beijing Tongrentang Group has issued an apology regarding the recent controversy surrounding "Antarctic Krill Oil," expressing deep concern for consumer rights and initiating a thorough investigation into the matter [1][3]. Group 1: Company Response - The company has launched a zero-tolerance brand management initiative and dispatched a special task force to Sichuan to conduct a comprehensive investigation into the involved products [3]. - The company has ordered the immediate removal of the implicated products from the market and is ensuring compliance with regulatory requirements for consumer compensation [3][4]. - Legal actions will be pursued against Sichuan Health and related e-commerce platforms for trademark infringement and misleading consumers [4]. Group 2: Product Investigation - The Shanghai Consumer Protection Committee has commissioned a study on 15 popular Antarctic krill oil products, focusing on their phospholipid, astaxanthin, EPA, and DHA content [5]. - A product labeled "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to have a phospholipid content of 0%, despite claims of high quality and purity [5]. - The committee plans to interview the manufacturers and distributors of the product to clarify the discrepancies in product claims [5].

Core Viewpoint - Tongrentang Group issued an apology regarding the controversy over "Antarctic krill oil," acknowledging consumer rights damage and committing to a zero-tolerance brand management initiative [1] Group 1: Company Actions - The company has initiated a special task force to conduct a thorough investigation of the implicated products in Sichuan, ensuring a comprehensive inquiry [1] - The company has ordered the immediate removal of the implicated products from the market and will supervise compliance with regulatory requirements for consumer compensation [1] - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading practices [1] Group 2: Product Investigation - The Shanghai Consumer Protection Commission tested 15 popular Antarctic krill oil products, revealing that one product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" had a phospholipid content of 0, indicating potential fraud [4] - The implicated product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, Sichuan Health Pharmaceutical, with production outsourced to Anhui Habao Pharmaceutical, representing a typical private label model [7] Group 3: Brand Management Issues - The product in question was produced without authorization to prominently feature the "Beijing Tongrentang" name, leading to legal proceedings initiated by the company against the involved entities [7] - Beijing Tongrentang, the sole legal holder of the "Tongrentang" trademark, has faced trust issues due to repeated incidents of private label mismanagement, raising concerns about brand authorization and quality control [7]